Apr 11, 2022 | Life Sciences, Portfolio Companies, Safar News
CAMBRIDGE, Mass. — April 11, 2022 — Lucy Therapeutics (LucyTx), a biotech with a unifying mitochondrial platform, today announced it secured funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), the largest nonprofit funder of...
Jan 11, 2022 | Life Sciences, Safar News
BOSTON, Jan. 11, 2022 (GLOBE NEWSWIRE) — Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for...
Feb 15, 2021 | Life Sciences, Portfolio Companies
ACS – “Amy Ripka is CEO of Lucy Therapeutics, a Boston-based, mitochondrial platform biotech, revolutionizing treatments for rare and neurological diseases. Previous to her role at LucyTx, she served on the executive leadership teams at SAI Life Sciences...
Sep 22, 2020 | Life Sciences, Portfolio Companies
We are excited to announce that HCO co-founder Sharon Samjitsingh has been named 2020 Tech Woman of the Year by TechRochester! 2020 Tech Woman of the Year Health Care Originals Inc. (HCO) is a leading digital health startup, integrating IoT...
Feb 14, 2020 | AI / IT / Robotics, Life Sciences, Portfolio Companies
Forbes highlights the Safar portfolio company Embr Labs together with Singfit, a music therapy app, and Alcove VR, a virtual reality app that promotes social engagement. All three companies use technology to empower people as they age! _____________ As Americans over...
Oct 7, 2019 | Life Sciences, Portfolio Companies
ROCHESTER, N.Y., Oct. 7, 2019 /PRNewswire-PRWeb/ — Clerio Vision has named John Weberg as Cornea Chief Commercialization Officer to further expand the development of its cornea business, which includes continued research and development, clinical trials and...
